EP3215159
APILIMOD FOR USE IN THE TREATMENT OF COLORECTAL CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
6.11.2015EP published:
21.7.2021EP application number:
15795319.1
EPO information:
European Patent Register
Max expiry date:
5.11.2035
Title:
APILIMOD FOR USE IN THE TREATMENT OF COLORECTAL CANCER
Timeline
Today
6.11.2015EP application
21.7.2021EP Publication
Owner
Name:
AI Therapeutics, Inc.Address:
530 Old Whitfield Street, Guilford, CT 06437, US
Inventor
Name:
BEEHARRY, NeilAddress:
Guilford, CT 06437, US
Name:
GAYLE, SophiaAddress:
Guilford, CT 06437, US
Name:
LANDRETTE, SeanAddress:
Guilford, CT 06437, US
Name:
BECKETT, PaulAddress:
Guilford, CT 06437, US
Name:
CONRAD, ChrisAddress:
Guilford, CT 06437, US
Name:
XU, TianAddress:
Guilford, CT 06437, US
Name:
HERNANDEZ, MarylensAddress:
Guilford, CT 06437, US
Name:
ROTHBERG, Jonathan M.Address:
Guilford, CT 06437, US
Name:
LICHENSTEIN, HenriAddress:
Guilford, CT 06437, US
Priority
Number:
201462077127 PDate:
7.11.2014Country:
US
Number:
201562115228 PDate:
12.2.2015Country:
US
Number:
201562119540 PDate:
23.2.2015Country:
US
Classification
Categories:
A61K 31/5377, A61K 31/44, A61K 31/437, A61P 35/00, A61P 35/04, A61K 45/06, G01N 33/50, G01N 33/574